Describe your industry experience:
I am a board-certified physician and an experienced Health Care Executive. As an industry leader, my career in health care spans over 25 years including clinical practice, direct patient care, health management and as an executive in pharmaceutical/biotechnology/ medical device product development. I am experienced in both US and global markets and have lead medical, scientific and operational teams across the breadth of geographic regions in established as well as emerging markets.
Describe your functional experience:
I have worked extensively in product development with R&D, commercial and marketing groups to develop medically sound strategies for safe and efficacious new products. One of my most important responsibilities lies in ensuring that clinical research subjects are appropriate for a particular study and safe during their participation in a clinical research study. I have been a Global Medical Advisor for clinical trials Phases 1-4 conducted in the United States, Europe, Latin America and Asia on thousands of clinical trial patients and draw on my clinical practice experience and scientific judgment to make decisions regarding patient safety.
Describe your key business transactional experience:
I have held numerous leadership positions of increasing scope and accountability, across a range of therapeutic areas. My business operations and change management expertise have been instrumental in aligning processes to optimize delivery of medical services across global regions and therapeutic areas in Quintiles, resulting in significant impact on P&L. I have a strong track record in revenue growth and have increased net new business by over $200 M during my tenure at Quintiles.
What is the most important skill you bring to a corporate board?
I have an in-depth understanding of the changing Healthcare regulatory environment in clinical development as well as healthcare delivery. From my experiences as a practicing Ob/Gyn physician, I am acquainted with the role evidence based medicine plays in health care decision making. Additionally, I understand the business implications of the changes in the regulatory and public policy arena and their impact on delivering quality healthcare. I am well versed in the global regulatory landscape, and, am a subject matter expert in health care policy such as the Affordable Care Act, Payment Reform, and FDASIA 907 having provided numerous trainings to constituent audiences comprised of both physicians, patients and health advocates. I have a track record of establishing strategic alliances with FDA, HHS, CMS, Congressional Staff, Office of the National Coordinator, patient advocacy organizations and other related stakeholders.
